Shattuck Labs (STTK) Cash & Equivalents (2019 - 2026)

Shattuck Labs (STTK) has 8 years of Cash & Equivalents data on file, last reported at $90.4 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 48.48% year-over-year to $90.4 million in Q1 2026; TTM through Mar 2026 was $90.4 million, a 48.48% increase from a year earlier, with the FY2025 full-year figure at $54.2 million, down 5.57% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $90.4 million, up from $54.2 million in the prior quarter.
• Over the last five years, Cash & Equivalents for STTK reached as high as $125.6 million in Q4 2023 and fell as low as $37.9 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $59.8 million across 5 years, with a median of $54.2 million in 2025.
• Across the five-year window, Cash & Equivalents sank 56.22% in 2022 and soared 165.15% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $47.4 million in 2022, then surged by 165.15% to $125.6 million in 2023, then tumbled by 54.32% to $57.4 million in 2024, then decreased by 5.57% to $54.2 million in 2025, then jumped by 66.85% to $90.4 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $90.4 million in Q1 2026, $54.2 million in Q4 2025, and $42.5 million in Q3 2025.